Bharat Biotech

Centre Revises Rates For Procuring Covishield & Covaxin, Places Order To Get 66 Crore Doses: Report

Covaxin Closer To WHO Approval? Covid-19 Vaccine Trial Data 'Looks Good', Says Chief Scientist

Coronavirus HIGHLIGHTS: Over 2 Crore 'Unutilised' COVID-19 Vaccine Doses Still Available With States, Says Govt

Coronavirus HIGHLIGHTS: Goa Govt Allows Bars, Restaurants To Function With 50% Seating Capacity

Coronavirus HIGHLIGHTS: Delhi Reports 86 New Covid Cases, 5 Deaths In Last 24 Hours

'Covaxin Found To Be 77.8% Effective In Final Analysis Of Phase III Trials', Claims Bharat Biotech

Coronavirus HIGHLIGHTS: Zydus Cadila Application For Zycov Jab Under Evaluation, Says Niti Aayog

Coronavirus HIGHLIGHTS: Confident Of Getting EMA's Approval In A month For Covishield, Says SII Chief Adar Poonawalla

Covaxin Effectively Neutralises Covid-19's Alpha & Delta Variant: US Health Research Institute

'Pricing Clearly Established For Supplies Outside India': Bharat Biotech On Brazil Covaxin Deal Controversy

Brazil To Suspend USD 324 Million Covaxin Vaccine Deal Over Accusations Of Irregularities

Brazil Govt Faces Probe For Choosing Bharat Biotech's Covaxin Deal Over 'Cheaper' Pfizer Vaccine | All About Controversy